Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $898.25 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $247.72 | 15 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $138.76 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $84.01 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $76.28 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.39 | 3 | $0 (2024) |
| Exact Sciences Corporation | $58.12 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $57.40 | 2 | $0 (2024) |
| Lilly USA, LLC | $41.53 | 2 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $40.93 | 2 | $0 (2024) |
| Eisai Inc. | $31.18 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $874.99 | 47 | Novo Nordisk Inc ($247.72) |
| 2022 | $23.26 | 1 | GlaxoSmithKline, LLC. ($23.26) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.66 | General |
| 12/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Obesity | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.18 | General |
| 11/15/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Insomnia | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Obesity | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: Obesity | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.44 | General |
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Obesity | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 49 | 49 | $10,226 | $4,108 |
| 2021 | 2 | 42 | 43 | $9,482 | $3,311 |
| 2020 | 3 | 105 | 111 | $23,605 | $9,347 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 24 | $5,248 | $2,148 | 40.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $3,178 | $1,228 | 38.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $1,800 | $732.28 | 40.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 31 | $6,758 | $2,261 | 33.5% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 12 | 12 | $2,724 | $1,050 | 38.6% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 45 | 49 | $10,859 | $4,301 | 39.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 46 | 48 | $10,464 | $4,147 | 39.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 14 | 14 | $2,282 | $899.42 | 39.4% |
About Mengxi Chen
Mengxi Chen is a Adult Health healthcare provider based in Little Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1457753717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mengxi Chen has received a total of $898.25 in payments from pharmaceutical and medical device companies, with $874.99 received in 2024. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($898.25).
As a Medicare-enrolled provider, Chen has provided services to 196 Medicare beneficiaries, totaling 203 services with total Medicare billing of $16,766. Data is available for 3 years (2020–2022), covering 8 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Little Falls, NY
- Active Since 09/18/2014
- Last Updated 06/15/2015
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1457753717
Products in Payments
- VOQUEZNA (Drug) $138.76
- Wegovy (Drug) $112.99
- VERQUVO (Drug) $84.01
- LEQVIO (Drug) $76.28
- Cologuard Collection Kit (Device) $58.12
- QUVIVIQ (Drug) $40.93
- Leqembi (Drug) $31.18
- INJECTAFER (Drug) $29.00
- Vanflyta (Drug) $28.40
- OFEV (Drug) $25.48
- TRADJENTA (Drug) $23.73
- BEXSERO (Biological) $23.26
- ZEPBOUND (Drug) $21.43
- JARDIANCE (Drug) $20.10
- BREZTRI (Drug) $17.81
- NEXLETOL (Drug) $14.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.